RidkerPM, DanielsonE, FonsecaFA, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med2008;359:2195–207
2.
Lloyd-JonesD, AdamsRJ, BrownTM, Heart disease and stroke statistics – 2010 update. A report from the American Heart Association. Circulation2010;121:e1–170
3.
CushmanM. Epidemiology and risk factors for venous thrombosis. Semin Hematol2007;44:62–9
4.
HenkeP, FroehlichJ, UpchurchGJr, WakefieldT. The significant negative impact of in-hospital venous thromboembolism after cardiovascular procedures. Ann Vasc Surg2007;21:545–50
5.
GangireddyC, RectenwaldJR, UpchurchGR, Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg2007;45:335–41; discussion 341–32
6.
LinJ, WakefieldTW, HenkePK. Risk factors associated with venous thromboembolic events in patients with malignancy. Blood Coagul Fibrinolysis2006;17:265–70
7.
KhoranaAA, KudererNM, CulakovaE, LymanGH, FrancisCW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood2008;111:4902–7
8.
OsborneNH, WakefieldTW, HenkePK. Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol2008;15:3567–78
9.
WakefieldTW, McLaffertyRB, LohrJM, CapriniJA, GillespieDL, PassmanMA. Call to action to prevent venous thromboembolism. J Vasc Surg2009;49:1620–3
10.
CohenAT, TapsonVF, BergmannJF, Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet2008;371:387–94
11.
GeertsW. Antithrombotic and thrombolytic therapy. Chest2008;133(8th Ed: ACCP Guidelines):p381s–451s
12.
CapriniJA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon2005;51:70–8
13.
BahlV, HuHM, HenkePK, WakefieldTW, CampbellDAJr, CapriniJA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg2010;251:344–50
14.
HatefDA, KenkelJM, NguyenMQ, Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg2008;122:269–79
15.
CapriniJA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg2010;199(Suppl. 1):S3–10
16.
GeertsWH, BergqvistD, PineoGF, Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest2008;133(Suppl. 6):p381S–453S
17.
LeonardiMJ, McGoryML, KoCY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg2006;141:790–7; discussion 797–9
18.
TurpieAG, BauerKA, CapriniJA, CompPC, GentM, MuntzJE. Fondaparinux combined with intermittent pneumatic compression versus intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost2007;5:1854–61
19.
BergqvistD, AgnelliG, CohenAT, Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med2002;346:975–80
20.
SweetlandS, GreenJ, LiuB, Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ2009;339:b4583
21.
KucherN, KooS, QuirozR, Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med2005;352:969–77
22.
HenkePK, FergusonE, VarmaM, DeatrickKB, WakefieldGT, WoodrumDT. Proximate versus nonproximate risk factor associated primary deep venous thrombosis: clinical spectrum and outcomes. J Vasc Surg2007;45:998–1003; discussion 1003–4; quiz 1005–7
23.
TooherR, MiddletonP, PhamC, A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg2005;241:397–415
24.
SteinPD, HullRD, PatelKC, d-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med2004;140:589–602
25.
HronG, KollarsM, BinderBR, EichingerS, KyrlePA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA2006;296:397–402
26.
SmithA, QuarmbyJW, CollinsM, LockhartSM, BurnandKG. Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost1999;82:1593–9
27.
RectenwaldJE, MyersDDJr, HawleyAE, d-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost2005;94:1312–17
